Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
Pt 3
pubmed:dateCreated
2007-6-15
pubmed:abstractText
Vasodilatation is a vital mechanism of systemic blood flow regulation that occurs during periods of increased energy demand. The AMP-dependent protein kinase (AMPK) is a serine/threonine kinase that is activated by conditions that increase the AMP-to-ATP ratio, such as exercise and metabolic stress. We hypothesized that AMPK could trigger vasodilatation and participate in blood flow regulation. Rings of thoracic aorta were isolated from C57Bl6 mice and mice deficient in the AMPK catalytic alpha1 (AMPKalpha1-/-) or alpha2 (AMPKalpha2-/-) subunit and their littermate controls, and mounted in an organ bath. Aortas were preconstricted with phenylephrine (1 microM) and activation of AMPK was induced by addition of increasing concentrations of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR). AICAR (0.1-3 mM) dose-dependently induced relaxation of precontracted C57BL6, AMPKalpha1+/+ and alpha2+/+ aorta (P<0.001, n=5-7 per group). This AICAR induced vasorelaxation was not inhibited by the addition of adenosine receptor antagonists. Moreover, when aortic rings were freed of endothelium by gentle rubbing, AICAR still induced aortic ring relaxation, suggesting a direct effect of AICAR on smooth muscle cells. When aortic rings were pretreated with L-NMMA (30 microM) to inhibit nitric oxide synthase activity, AICAR still induced relaxation. Western blot analysis of C57Bl6 mice denuded aorta showed that AMPK was phosphorylated after incubation with AICAR and that AMPKalpha1 was the main catalytic subunit expressed. Finally, AICAR-induced relaxation of aortic rings was completely abolished in AMPKalpha1-/- but not AMPKalpha2-/- mice. Taken together, the results show that activation of AMPKalpha1 but not AMPKalpha2 is able to induce aortic relaxation in mice, in an endothelium- and eNOS-independent manner.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-10025949, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-12086950, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-12511592, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-12689619, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-12788940, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-12791703, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-12829246, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-14506307, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-14573616, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-15261476, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-15265871, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-15377643, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-16151020, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-16199527, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-16318863, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-16439434, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-16443786, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-16497986, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-16686439, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-2984420, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-7744080, http://linkedlifedata.com/resource/pubmed/commentcorrection/17446219-7896049
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0022-3751
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
581
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1163-71
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:17446219-AMP-Activated Protein Kinases, pubmed-meshheading:17446219-Aminoimidazole Carboxamide, pubmed-meshheading:17446219-Animals, pubmed-meshheading:17446219-Aorta, Thoracic, pubmed-meshheading:17446219-Dose-Response Relationship, Drug, pubmed-meshheading:17446219-Enzyme Activation, pubmed-meshheading:17446219-Enzyme Activators, pubmed-meshheading:17446219-Isoenzymes, pubmed-meshheading:17446219-Mice, pubmed-meshheading:17446219-Mice, Inbred C57BL, pubmed-meshheading:17446219-Mice, Knockout, pubmed-meshheading:17446219-Multienzyme Complexes, pubmed-meshheading:17446219-Muscle, Smooth, Vascular, pubmed-meshheading:17446219-Phosphorylation, pubmed-meshheading:17446219-Protein-Serine-Threonine Kinases, pubmed-meshheading:17446219-Ribonucleotides, pubmed-meshheading:17446219-Vasodilation
pubmed:year
2007
pubmed:articleTitle
Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice.
pubmed:affiliation
Université Paris-Sud, IFR-141, Châtenay-Malabry, France. goirand.francoise@wanadoo.fr
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't